To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer SEMINARS IN RADIATION ONCOLOGY Shultz, D. B., Diehn, M., Loo, B. W. 2015; 25 (2): 78-86

View details for DOI 10.1016/j.semradonc.2014.11.005

View details for Web of Science ID 000351254100003